All Stories

  1. GABAB Receptor Modulation of Membrane Excitability in Human Pluripotent Stem Cell‐Derived Sensory Neurons by Baclofen and α‐Conotoxin Vc1.1
  2. Molecular determinants of the selectivity and potency of α-conotoxin Vc1.1 for human nicotinic acetylcholine receptors
  3. Development of an Intravenously Stable Disulfide-Rich Peptide for the Treatment of Chemotherapy-Induced Neuropathic Pain
  4. Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases
  5. Nicotinic acetylcholine receptor subtype expression, function, and pharmacology: Therapeutic potential of α-conotoxins
  6. Characterisation of Elevenin-Vc1 from the Venom of Conus victoriae: A Structural Analogue of α-Conotoxins
  7. Advances in Xanthan Gum-Based Systems for the Delivery of Therapeutic Agents
  8. Mechanism of Action and Structure–Activity Relationship of α-Conotoxin Mr1.1 at the Human α9α10 Nicotinic Acetylcholine Receptor
  9. Analgesic α-Conotoxin Binding Site on the Human GABAB Receptor
  10. Single-Disulfide Conopeptide Czon1107, an Allosteric Antagonist of the Human α3β4 Nicotinic Acetylcholine Receptor
  11. µ-Theraphotoxin Pn3a inhibition of CaV3.3 channels reveals a novel isoform-selective drug binding site
  12. Identification of a sensory neuron Cav2.3 inhibitor within a new superfamily of macro-conotoxins
  13. Glycinergic Modulation of Pain in Behavioral Animal Models
  14. A 4/8 Subtype α-Conotoxin Vt1.27 Inhibits N-Type Calcium Channels With Potent Anti-Allodynic Effect
  15. Cysteine-Rich α-Conotoxin SII Displays Novel Interactions at the Muscle Nicotinic Acetylcholine Receptor
  16. Automated patch clamp screening of amiloride and 5-N,N-hexamethyleneamiloride (HMA) analogs identifies 6-iodoamiloride as a potent acid-sensing ion channel inhibitor
  17. Multitarget nociceptor sensitization by a promiscuous peptide from the venom of the King Baboon spider
  18. Antagonism of Saxitoxin and Tetrodotoxin Block by Internal Monovalent Cations in Squid Axon
  19. Analgesic α‐conotoxins modulate native and recombinant GIRK1/2 channels via activation of GABA B receptors and reduce neuroexcitability
  20. ɑO‐Conotoxin GeXIVA isomers modulate N‐type calcium (Ca V 2.2) channels and inwardly‐rectifying potassium (GIRK) channels via GABA B receptor activation
  21. μ-Theraphotoxin-Pn3a inhibition of CaV3.3 channels reveals a novel isoform-selective drug binding site
  22. Electrical properties and synaptic transmission in mouse intracardiac ganglion neurons in situ
  23. Globular and ribbon isomers of Conus geographus α-conotoxins antagonize human nicotinic acetylcholine receptors
  24. α‐Conotoxin Bt1.8 from Conus betulinus selectively inhibits α6/α3β2β3 and α3β2 nicotinic acetylcholine receptor subtypes
  25. Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor
  26. Alkyne-Bridged α-Conotoxin Vc1.1 Potently Reverses Mechanical Allodynia in Neuropathic Pain Models
  27. Trends in peptide drug discovery
  28. Spider Venom Peptide Pn3a Inhibition of Primary Afferent High Voltage-Activated Calcium Channels
  29. Venom-Derived Peptides Inhibiting Voltage-Gated Sodium and Calcium Channels in Mammalian Sensory Neurons
  30. Functional modulation of the human voltage-gated sodium channel NaV1.8 by auxiliary β subunits
  31. Molecular and Functional Characterization of Neurogenin-2 Induced Human Sensory Neurons
  32. Analgesic α-conotoxins modulate GIRK1/2 channels via GABABreceptor activation and reduce neuroexcitability
  33. (E)-3-Furan-2-yl-N-p-tolyl-acrylamide and its Derivative DM489 Decrease Neuropathic Pain in Mice Predominantly by α7 Nicotinic Acetylcholine Receptor Potentiation
  34. A method for high-content functional imaging of intracellular calcium responses in gelatin-immobilized non-adherent cells
  35. N-acetyl-d-glucosamine-conjugated PAMAM dendrimers as dual receptor-targeting nanocarriers for anticancer drug delivery
  36. Coronaridine congeners decrease neuropathic pain in mice and inhibit α9α10 nicotinic acetylcholine receptors and CaV2.2 channels
  37. Rational Design of α-Conotoxin RegIIA Analogues Selectively Inhibiting the Human α3β2 Nicotinic Acetylcholine Receptor through Computational Scanning
  38. Interactions of the α3β2 Nicotinic Acetylcholine Receptor Interfaces with α-Conotoxin LsIA and its Carboxylated C-terminus Analogue: Molecular Dynamics Simulations
  39. Structural basis of the potency and selectivity of Urotoxin, a potent Kv1 blocker from scorpion venom
  40. Ketamine inhibits synaptic transmission in rat intracardiac ganglia.
  41. Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors
  42. Fulditoxin, representing a new class of dimeric snake toxins, defines novel pharmacology at nicotinic ACh receptors
  43. On-Resin Strategy to Label α-Conotoxins: Cy5-RgIA, a Potent α9α10 Nicotinic Acetylcholine Receptor Imaging Probe
  44. An environmentally sustainable biomimetic production of cyclic disulfide-rich peptides
  45. Bombesin receptors as potential targets for anticancer drug delivery and imaging
  46. α-Conotoxin Vc1.1 Structure–Activity Relationship at the Human α9α10 Nicotinic Acetylcholine Receptor Investigated by Minimal Side Chain Replacement
  47. Molecular dynamics simulations of dihydro‐β‐erythroidine bound to the human α4β2 nicotinic acetylcholine receptor
  48. Analgesic transient receptor potential vanilloid‐1‐active compounds inhibit native and recombinant T‐type calcium channels
  49. Drysdalin, an antagonist of nicotinic acetylcholine receptors highlights the importance of functional rather than structural conservation of amino acid residues
  50. Monoclonal Antibody-Conjugated Dendritic Nanostructures for siRNA Delivery
  51. Targeting of N-Type Calcium Channels via GABAB-Receptor Activation by α-Conotoxin Vc1.1 Variants Displaying Improved Analgesic Activity
  52. NMR Structure of μ-Conotoxin GIIIC: Leucine 18 Induces Local Repacking of the N-Terminus Resulting in Reduced NaV Channel Potency
  53. Novel analgesic ω-conotoxins from the vermivorous cone snail Conus moncuri provide new insights into the evolution of conopeptides
  54. Stoichiometry dependent inhibition of rat α3β4 nicotinic acetylcholine receptor by the ribbon isomer of α-conotoxin AuIB
  55. Molecular Determinants Conferring the Stoichiometric-Dependent Activity of α-Conotoxins at the Human α9α10 Nicotinic Acetylcholine Receptor Subtype
  56. Structure–Activity Studies Reveal the Molecular Basis for GABAB-Receptor Mediated Inhibition of High Voltage-Activated Calcium Channels by α-Conotoxin Vc1.1
  57. Contribution of membrane receptor signalling to chronic visceral pain
  58. Cyclic analogues of α‐conotoxin Vc1.1 inhibit colonic nociceptors and provide analgesia in a mouse model of chronic abdominal pain
  59. A novel α-conopeptide Eu1.6 inhibits N-type (CaV2.2) calcium channels and exhibits potent analgesic activity
  60. Neuropharmacology of venom peptides
  61. In vivo and in vitro testing of native α-conotoxins from the injected venom of Conus purpurascens
  62. Analgesic conopeptides targeting G protein-coupled receptors reduce excitability of sensory neurons
  63. Interaction of Synthetic Human SLURP-1 with the Nicotinic Acetylcholine Receptors
  64. Backbone cyclization of analgesic conotoxin GeXIVA facilitates direct folding of the ribbon isomer
  65. Role of CysI–CysIII Disulfide Bond on the Structure and Activity of α-Conotoxins at Human Neuronal Nicotinic Acetylcholine Receptors
  66. Inhibition of human N- and T-type calcium channels by an ortho -phenoxyanilide derivative, MONIRO-1
  67. Nanoparticle targeted delivery of camptothecin to glioma
  68. α‐Conotoxins active at α3‐containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition
  69. Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine Receptor
  70. A Novel Lid-Covering Peptide Inhibitor of Nicotinic Acetylcholine Receptors Derived from αD-Conotoxin GeXXA
  71. The tarantula toxin β/δ-TRTX-Pre1a highlights the importance of the S1-S2 voltage-sensor region for sodium channel subtype selectivity
  72. Effects of linker sequence modifications on the structure, stability, and biological activity of a cyclic α-conotoxin
  73. Store-Operated Ca2+ Entry (SOCE) and Purinergic Receptor-Mediated Ca2+ Homeostasis in Murine bv2 Microglia Cells: Early Cellular Responses to ATP-Mediated Microglia Activation
  74. Improving Efficacy, Oral Bioavailability, and Delivery of Paclitaxel Using Protein-Grafted Solid Lipid Nanoparticles
  75. Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H
  76. Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins
  77. Formulation and dosage of therapeutic nanosuspension for active targeting of docetaxel (WO 2014210485A1)
  78. Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer
  79. Cyclic RGDfK Peptide Functionalized Polymeric Nanocarriers for Targeting Gemcitabine to Ovarian Cancer Cells
  80. Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High-Voltage-Activated Calcium Channels via GABAB Receptor Activation Reveal a Minimal Functional Motif
  81. α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABA B receptors
  82. Modulation of human Nav1.7 channel gating by synthetic α-scorpion toxin OD1 and its analogs
  83. Transforming conotoxins into cyclotides: Backbone cyclization of P-superfamily conotoxins
  84. Voltage-Gated R-Type Calcium Channel Inhibition via Human μ-, δ-, and κ-opioid Receptors Is Voltage-Independently Mediated by Gβγ Protein Subunits
  85. A Distinct Functional Site in Ω-Neurotoxins: Novel Antagonists of Nicotinic Acetylcholine Receptors from Snake Venom
  86. Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors
  87. Conotoxin αD-GeXXA utilizes a novel strategy to antagonize nicotinic acetylcholine receptors
  88. Bombesin-conjugated nanoparticles improve the cytotoxic efficacy of docetaxel against gastrin-releasing but androgen-independent prostate cancer
  89. Less is More: Design of a Highly Stable Disulfide-Deleted Mutant of Analgesic Cyclic α-Conotoxin Vc1.1
  90. Cyclic-RGDfK peptide conjugated succinoyl-TPGS nanomicelles for targeted delivery of docetaxel to integrin receptor over-expressing angiogenic tumours
  91. Biomedical Applications of Trastuzumab: As a Therapeutic Agent and a Targeting Ligand
  92. α-Conotoxin Dendrimers Have Enhanced Potency and Selectivity for Homomeric Nicotinic Acetylcholine Receptors
  93. Inhibition of cholinergic pathways in Drosophila melanogaster by α-conotoxins
  94. Cyclic-RGDfK-Directed Docetaxel Loaded Nanomicelles for Angiogenic Tumor Targeting
  95. Inhibition of Human CaV2.3 Channels via μ-, δ- and κ-Opioid Receptor Activation
  96. Venom-based drug discovery
  97. Dicarba Analogues of α-Conotoxin RgIA. Structure, Stability, and Activity at Potential Pain Targets
  98. Novel Mechanism of Voltage-Gated N-type (Cav2.2) Calcium Channel Inhibition Revealed through α-Conotoxin Vc1.1 Activation of the GABAB Receptor
  99. Alanine Scan of α-Conotoxin RegIIA Reveals a Selective α3β4 Nicotinic Acetylcholine Receptor Antagonist
  100. Hydrophobic residues at position 10 of α-conotoxin PnIA influence subtype selectivity between α7 and α3β2 neuronal nicotinic acetylcholine receptors
  101. Effects of arginine 10 to lysine substitution on ω-conotoxin CVIE and CVIF block of Cav2.2 channels
  102. Isolation, synthesis and characterization of ω-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type CaV channels
  103. 888 α-Conotoxin Vc1.1 Targets GABAB Receptors Modulating CaV2.2 and CaV2.3 Calcium Channels in Sensory Pathways Mediating Chronic Visceral Pain
  104. Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABABreceptor activation
  105. Are nicotinic acetylcholine receptors coupled to G proteins?
  106. Identifying Key Amino Acid Residues That Affect α-Conotoxin AuIB Inhibition of α3β4 Nicotinic Acetylcholine Receptors
  107. Isolation and characterization of α-conotoxin LsIA with potent activity at nicotinic acetylcholine receptors
  108. Mechanisms of conotoxin inhibition of N-type (Cav2.2) calcium channels
  109. Dicarba α-Conotoxin Vc1.1 Analogues with Differential Selectivity for Nicotinic Acetylcholine and GABAB Receptors
  110. Determination of the α-Conotoxin Vc1.1 Binding Site on the α9α10 Nicotinic Acetylcholine Receptor
  111. Kv3.1 channels stimulate adult neural precursor cell proliferation and neuronal differentiation
  112. Chemical Engineering and Structural and Pharmacological Characterization of the α-Scorpion Toxin OD1
  113. Conotoxins Targeting Neuronal Voltage-Gated Sodium Channel Subtypes: Potential Analgesics?
  114. Isolation, characterization and total regioselective synthesis of the novel μO-conotoxin MfVIA from Conus magnificus that targets voltage-gated sodium channels
  115. Biophysical properties of Nav1.8/Nav1.2 chimeras and inhibition by µO-conotoxin MrVIB
  116. Intrathecal α-conotoxins Vc1.1, AuIB and MII acting on distinct nicotinic receptor subtypes reverse signs of neuropathic pain
  117. γ-Aminobutyric Acid Type B (GABAB) Receptor Expression Is Needed for Inhibition of N-type (Cav2.2) Calcium Channels by Analgesic α-Conotoxins
  118. Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (CaV2.2) calcium channels
  119. Localization of Nav1.7 in the normal and injured rodent olfactory system indicates a critical role in olfaction, pheromone sensing and immune function
  120. RegIIA: An α4/7-conotoxin from the venom of Conus regius that potently blocks α3β4 nAChRs
  121. Effects of Cyclization on Stability, Structure, and Activity of α-Conotoxin RgIA at the α9α10 Nicotinic Acetylcholine Receptor and GABABReceptor
  122. Correction to “Analgesic ω-Conotoxins CVIE and CVIF Selectively and Voltage-Dependently Block Recombinant and Native N-Type Calcium Channels”: TABLE 1
  123. Purification of Immature Neuronal Cells from Neural Stem Cell Progeny
  124. Total Synthesis of the Analgesic Conotoxin MrVIB through Selenocysteine-Assisted Folding
  125. Total Synthesis of the Analgesic Conotoxin MrVIB through Selenocysteine-Assisted Folding
  126. Embryonic Toxin Expression in the Cone Snail Conus victoriae: PRIMED TO KILL OR DIVERGENT FUNCTION?
  127. A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain
  128. Structure and Activity of α-Conotoxin PeIA at Nicotinic Acetylcholine Receptor Subtypes and GABABReceptor-coupled N-type Calcium Channels
  129. Regulation of voltage-gated ion channels in excitable cells by the ubiquitin ligases Nedd4 and Nedd4-2
  130. Stabilization of α-Conotoxin AuIB: Influences of Disulfide Connectivity and Backbone Cyclization
  131. The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain
  132. Physiological roles of ion channels in adult neural stem cells and their progeny
  133. The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain
  134. α-Conotoxin AuIB Isomers Exhibit Distinct Inhibitory Mechanisms and Differential Sensitivity to Stoichiometry of α3β4 Nicotinic Acetylcholine Receptors
  135. Solving the α-Conotoxin Folding Problem: Efficient Selenium-Directed On-Resin Generation of More Potent and Stable Nicotinic Acetylcholine Receptor Antagonists
  136. Coordinate regulation of stretch-activated channels and myogenic tone by polycystins 1 and 2
  137. Analgesic α-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice
  138. Analgesic ω-Conotoxins CVIE and CVIF Selectively and Voltage-Dependently Block Recombinant and Native N-Type Calcium Channels
  139. Reactive oxygen species modulate neuronal excitability in rat intrinsic cardiac ganglia
  140. Chemical synthesis and folding of APETx2, a potent and selective inhibitor of acid sensing ion channel 3
  141. Scanning Mutagenesis of α-Conotoxin Vc1.1 Reveals Residues Crucial for Activity at the α9α10 Nicotinic Acetylcholine Receptor
  142. Mutations within the selectivity filter of the NMDA receptor-channel influence voltage dependent block by 5-hydroxytryptamine
  143. Intravenous anaesthetics inhibit nicotinic acetylcholine receptor-mediated currents and Ca2+ transients in rat intracardiac ganglion neurons
  144. Intravenous anaesthetics inhibit nicotinic acetylcholine receptor-mediated currents and Ca2+ transients in rat intracardiac ganglion neurons
  145. Inhibition of Neuronal Nicotinic Acetylcholine Receptor Subtypes by α-Conotoxin GID and Analogues
  146. Analgesic  -Conotoxins Vc1.1 and Rg1A Inhibit N-Type Calcium Channels in Rat Sensory Neurons via GABAB Receptor Activation
  147. ω-Conotoxin inhibition of excitatory synaptic transmission evoked by dorsal root stimulation in rat superficial dorsal horn
  148. Molecular Engineering of Conotoxins: The Importance of Loop Size to α-Conotoxin Structure and Function
  149. Regulation of the voltage-gated K+ channels KCNQ2/3 and KCNQ3/5 by serum- and glucocorticoid-regulated kinase-1
  150. Neuronally Selective μ-Conotoxins fromConus striatusUtilize an α-Helical Motif to Target Mammalian Sodium Channels
  151. Kir and Kv channels regulate electrical properties and proliferation of adult neural precursor cells
  152. The three-dimensional structure of the analgesic α-conotoxin, RgIA
  153. Conotoxin modulation of voltage-gated sodium channels
  154. Voltage-Gated Calcium Channels in Nociception
  155. NEDD4-2as a potential candidate susceptibility gene for epileptic photosensitivity
  156. Distinct activities of novel neurotoxins from Australian venomous snakes for nicotinic acetylcholine receptors
  157. Are α9α10 Nicotinic Acetylcholine Receptors a Pain Target for α-Conotoxins?
  158. Purinergic receptor activation inhibits mitogen-stimulated proliferation in primary neurospheres from the adult mouse subventricular zone
  159. Chemical Modification of Conotoxins to Improve Stability and Activity
  160. The Doublecortin-Expressing Population in the Developing and Adult Brain Contains Multipotential Precursors in Addition to Neuronal-Lineage Cells
  161. Regulation of the Voltage-gated K+Channels KCNQ2/3 and KCNQ3/5 by Ubiquitination
  162. Liposome reconstitution and modulation of recombinant N -methyl- d -aspartate receptor channels by membrane stretch
  163. Structure of α-conotoxin BuIA: influences of disulfide connectivity on structural dynamics
  164. ?-Conotoxin CVIB differentially inhibits native and recombinant N- and P/Q-type calcium channels
  165. Isolation and Structure-Activity of μ-Conotoxin TIIIA, A Potent Inhibitor of Tetrodotoxin-Sensitive Voltage-Gated Sodium Channels
  166. μO-conotoxin MrVIB selectively blocks Na v 1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits
  167. Identification of a Novel Class of Nicotinic Receptor Antagonists
  168. The Synthesis, Structural Characterization, and Receptor Specificity of the α-Conotoxin Vc1.1
  169. α-Selenoconotoxins, a New Class of Potent α7Neuronal Nicotinic Receptor Antagonists
  170. NMDA receptor subunit-dependent modulation by conantokin-G and Ala(7)-conantokin-G
  171. Neuronal voltage-gated sodium channel subtypes: Key roles in inflammatory and neuropathic pain
  172. Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the α-conotoxin MII
  173. Bee venom peptide blocks potassium channels
  174. Selective Modulation of Neuronal Nicotinic Acetylcholine Receptor Channel Subunits by Go-Protein Subunits
  175. Developmental changes in expression of GABAAreceptor-channels in rat intrinsic cardiac ganglion neurones
  176. Voltage-dependent inhibition of recombinant NMDA receptor-mediated currents by 5-hydroxytryptamine
  177. Auxiliary subunit regulation of high-voltage activated calcium channels expressed in mammalian cells
  178. The α2δ Auxiliary Subunit Reduces Affinity of ω-Conotoxins for Recombinant N-type (Cav2.2) Calcium Channels
  179. Adenosine Triphosphate Acts as Both a Competitive Antagonist and a Positive Allosteric Modulator at Recombinant N-Methyl-D-aspartate Receptors
  180. Functional maturation of isolated neural progenitor cells from the adult rat hippocampus
  181. Potassium Channels and Membrane Potential in the Modulation of Intracellular Calcium in Vascular Endothelial Cells
  182. Regulation of Neuronal Voltage-gated Sodium Channels by the Ubiquitin-Protein Ligases Nedd4 and Nedd4-2
  183. Structures of μO-conotoxins fromConus marmoreus
  184. Overexpressed Cavβ3 Inhibits N-type (Cav2.2) Calcium Channel Currents through a Hyperpolarizing Shift of “Ultra-slow” and “Closed-state” Inactivation
  185. Chemical and Functional Identification and Characterization of Novel Sulfated α-Conotoxins from the Cone Snail Conus a nemone
  186. Muscarinic and Nicotinic ACh Receptor Activation Differentially Mobilize Ca2+ in Rat Intracardiac Ganglion Neurons
  187. Inhibition of the Norepinephrine Transporter by the Venom Peptide χ-MrIA
  188. Allosteric α1-Adrenoreceptor Antagonism by the Conopeptide ρ-TIA
  189. α-Conotoxins PnIA and [A10L]PnIA Stabilize Different States of the α7-L247T Nicotinic Acetylcholine Receptor
  190. Synthesis, Structure Elucidation, in Vitro Biological Activity, Toxicity, and Caco-2 Cell Permeability of Lipophilic Analogues of α-Conotoxin MII
  191. ω-Conotoxin CVID Inhibits a Pharmacologically Distinct Voltage-sensitive Calcium Channel Associated with Transmitter Release from Preganglionic Nerve Terminals
  192. Isolation, Structure, and Activity of GID, a Novel α4/7-Conotoxin with an Extended N-terminal Sequence
  193. A New Level of Conotoxin Diversity, a Non-native Disulfide Bond Connectivity in α-Conotoxin AuIB Reduces Structural Definition but Increases Biological Activity
  194. Basal Nonselective Cation Permeability in Rat Cardiac Microvascular Endothelial Cells
  195. Ciguatoxin-induced oscillations in membrane potential and action potential firing in rat parasympathetic neurons
  196. Neural control of the heart: developmental changes in ionic conductances in mammalian intrinsic cardiac neurons
  197. Solution Structure of μ-Conotoxin PIIIA, a Preferential Inhibitor of Persistent Tetrodotoxin-sensitive Sodium Channels
  198. Pre- and postsynaptic actions of ATP on neurotransmission in rat submandibular ganglia
  199. Two new classes of conopeptides inhibit the α1-adrenoceptor and noradrenaline transporter
  200. An ATP-sensitive K+conductance in dissociated neurones from adult rat intracardiac ganglia
  201. ZNF265—a novel spliceosomal protein able to induce alternative splicing
  202. Ionic selectivity of native ATP-activated (P2X) receptor channels in dissociated neurones from rat parasympathetic ganglia
  203. Developmental Changes in Hyperpolarization-Activated CurrentsI h and I K(IR) in Isolated Rat Intracardiac Neurons
  204. Large-conductance calcium-activated potassium channels in neonatal rat intracardiac ganglion neurons
  205. Novel ω-Conotoxins fromConus catusDiscriminate among Neuronal Calcium Channel Subtypes
  206. VIP and PACAP potentiation of nicotinic ACh-evoked currents in rat parasympathetic neurons is mediated by G-protein activation
  207. P2Y purinoceptor activation mobilizes intracellular Ca2+and induces a membrane current in rat intracardiac neurones
  208. Single Amino Acid Substitutions in α-Conotoxin PnIA Shift Selectivity for Subtypes of the Mammalian Neuronal Nicotinic Acetylcholine Receptor
  209. Calcium channels controlling acetylcholine release from preganglionic nerve terminals in rat autonomic ganglia
  210. Met-enkephalin-induced mobilization of intracellular Ca2+ in rat intracardiac ganglion neurones
  211. Conotoxins and their potential pharmaceutical applications
  212. ACh- and caffeine-induced Ca2+mobilization and current activation in rabbit arterial endothelial cells
  213. Ciguatoxin (CTX-1) modulates single tetrodotoxin-sensitive sodium channels in rat parasympathetic neurones
  214. α-Conotoxin EpI, a Novel Sulfated Peptide fromConus episcopatusThat Selectively Targets Neuronal Nicotinic Acetylcholine Receptors
  215. M4 Muscarinic Receptor Activation Modulates Calcium Channel Currents in Rat Intracardiac Neurons
  216. The relationship of brevetoxin ‘length’ and A-ring functionality to binding and activity in neuronal sodium channels
  217. An ATP-sensitive potassium conductance in rabbit arterial endothelial cells.
  218. Monovalent and divalent cation permeability and block of neuronal nicotinic receptor channels in rat parasympathetic ganglia
  219. Caffeine-evoked, calcium-sensitive membrane currents in rabbit aortic endothelial cells
  220. TEA inhibits ACh-induced EDRF release: endothelial Ca(2+)-dependent K+ channels contribute to vascular tone
  221. Cytosolic [Ca2+] measurements in endothelium of rabbit cardiac valves using imaging fluorescence microscopy
  222. Local anaesthetic blockade of neuronal nicotinic ACh receptor-channels in rat parasympathetic ganglion cells
  223. Functional Properties of Background Chloride Channels
  224. Ionic channels in vascular endothelial cells
  225. Is the A-ring lactone of brevetoxin PbTX-3 required for sodium channel orphan receptor binding and activity?
  226. Voltage-dependent sodium and calcium currents in cultured parasympathetic neurones from rat intracardiac ganglia.
  227. Resting membrane potential and potassium currents in cultured parasympathetic neurones from rat intracardiac ganglia.
  228. Calcium-activated potassium channels in native endothelial cells from rabbit aorta: conductance, Ca2+ sensitivity and block.
  229. Calcium permeability and modulation of nicotinic acetylcholine receptor-channels in rat parasympathetic neurons
  230. Acetylcholine-evoked currents in cultured neurones dissociated from rat parasympathetic cardiac ganglia.
  231. Bradykinin and inositol 1,4,5-trisphosphate-stimulated calcium release from intracellular stores in cultured bovine endothelial cells
  232. Calcium entry through receptor-operated channels in bovine pulmonary artery endothelial cells
  233. Inhibitors of calcium buffering depress evoked transmitter release at the squid giant synapse.
  234. Interaction of internal anions with potassium channels of the squid giant axon.
  235. Divalent ion currents and the delayed potassium conductance in an Aplysia neurone.
  236. Ionic Currents in Molluscan Soma
  237. Sodium and calcium gating currents in an Aplysia neurone.
  238. Characteristics of sodium and calcium conductance changes produced by membrane depolarization in an Aplysia neurone.
  239. Ionic currents in response to membrane depolarization in an Aplysia neurone.
  240. Asymmetrical displacement currents
  241. Ethanol reduces excitatory postsynaptic current duration at a crustacean neuromuscular junction
  242. Funnel web spider venom produces spontaneous action potentials in nerve
  243. Voltage sensitivity of inhibitory postsynaptic currents inAplysia buccal ganglia
  244. Block of Voltage-Gated Calcium Channels by Peptide Toxins